PITTSBURGH, June 13, 2024 – New University of Pittsburgh research points to a potential approach to reducing the risk of diabetes associated with widely prescribed antipsychotic medications. The study ...

A study analyzed data from nearly 500,000 Canadian patients who lived in nursing homes across Canada between 2000 and 2022. It found that residents who were given antipsychotic medications showed a ...

The drugmaker is testing its antipsychotic drug Cobenfy for the treatment of psychosis associated with Alzheimer’s disease.

In a recent British Medical Journal study, researchers assess the adverse effects associated with the use of antipsychotic drugs in people with dementia. Study: Multiple adverse outcomes associated ...

Boehringer Ingelheim plans to submit its app to treat under-addressed symptoms of schizophrenia for FDA clearance.

Among patients with schizophrenia whose medication is changed because of ineffectiveness or harmful side effects, second-generation antipsychotic drugs do not appear to offer significant benefits ...

Is the first pill just the beginning? For many children diagnosed with attention-deficit/hyperactivity disorder, a ...

Since the first antipsychotic medication, chlorpromazine, was developed in the early 1950s, it could be argued that not all that much has changed in the pharmacological treatment of psychotic ...

Researchers at Orygen have found that some young people with early stage first episode psychosis (FEP) can experience reduced symptoms and improve functioning without antipsychotic medication when ...

SCOTTSDALE, Arizona — Atypical antipsychotics, though not typically considered drugs of abuse, are now being used to enhance the effects of other drugs or as a way to counter the adverse effects of ...